Wedbush Securities’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-6,181
| Closed | -$614K | – | 1065 |
|
|
2019
Q3 | $614K | Buy |
6,181
+322
| +5% | +$30.6K | 0.06% | 368 |
|
|
2019
Q2 | $542K | Sell |
5,859
-5,786
| -50% | -$549K | 0.05% | 399 |
|
|
2019
Q1 | $1.1M | Sell |
11,645
-13,770
| -54% | -$1.2M | 0.12% | 203 |
|
|
2018
Q4 | $1.63M | Sell |
25,415
-5,869
| -19% | -$433K | 0.21% | 115 |
|
|
2018
Q3 | $2.8M | Sell |
31,284
-2,396
| -7% | -$212K | 0.32% | 60 |
|
|
2018
Q2 | $2.67M | Sell |
33,680
-14,762
| -30% | -$1.23M | 0.33% | 53 |
|
|
2018
Q1 | $4.32M | Buy |
48,442
+6,135
| +15% | +$589K | 0.56% | 27 |
|
|
2017
Q4 | $4.42M | Buy |
42,307
+13,995
| +49% | +$1.58M | 0.54% | 33 |
|
|
2017
Q3 | $4.13M | Sell |
28,312
-3,165
| -10% | -$431K | 0.54% | 34 |
|
|
2017
Q2 | $4.09M | Buy |
31,477
+600
| +2% | +$73.5K | 0.53% | 29 |
|
|
2017
Q1 | $3.84M | Buy |
30,877
+2,778
| +10% | +$332K | 0.52% | 29 |
|
|
2016
Q4 | $3.25M | Buy |
28,099
+227
| +0.8% | +$25.3K | 0.48% | 33 |
|
|
2016
Q3 | $2.91M | Buy |
27,872
+3,323
| +14% | +$360K | 0.43% | 43 |
|
|
2016
Q2 | $2.42M | Buy |
24,549
+118
| +0.5% | +$12.2K | 0.4% | 51 |
|
|
2016
Q1 | $2.44M | Buy |
24,431
+2,789
| +13% | +$287K | 0.42% | 43 |
|
|
2015
Q4 | $2.59M | Sell |
21,642
-1,511
| -7% | -$175K | 0.47% | 39 |
|
|
2015
Q3 | $2.5M | Sell |
23,153
-1,388
| -6% | -$172K | 0.5% | 33 |
|
|
2015
Q2 | $2.84M | Buy |
24,541
+13
| +0.1% | +$1.49K | 0.52% | 23 |
|
|
2015
Q1 | $2.83M | Buy |
24,528
+1,360
| +6% | +$163K | 0.48% | 32 |
|
|
2014
Q4 | $2.59M | Sell |
23,168
-2,539
| -10% | -$268K | 0.4% | 39 |
|
|
2014
Q3 | $2.44M | Sell |
25,707
-57
| -0.2% | -$5.14K | 0.38% | 45 |
|
|
2014
Q2 | $2.21M | Buy |
25,764
+684
| +3% | +$52K | 0.35% | 58 |
|
|
2014
Q1 | $1.75M | Buy |
25,080
+3,426
| +16% | +$271K | 0.31% | 74 |
|
|
2013
Q4 | $1.83M | Buy |
21,654
+1,668
| +8% | +$132K | 0.43% | 57 |
|
|
2013
Q3 | $1.54M | Buy |
19,986
+1,278
| +7% | +$89.6K | 0.41% | 65 |
|
|
2013
Q2 | $1.09M | Buy |
+18,708
| New | +$1.13M | 0.3% | 90 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Wedbush Securities's CELG Position: Q4 2019 in Review
Wedbush Securities sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,181 shares — an estimated $614K sold.
Wedbush Securities first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.42M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Wedbush Securities reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Wedbush Securities sold 6,181 Celgene Corp shares in Q4 2019, an estimated $614K.
- Wedbush Securities first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Wedbush Securities's Celgene Corp position peaked at $4.42M in Q4 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Wedbush Securities's 13F filing for Q4 2019, filed 16 Jan 2020.